Education
About Us
Working with TipRanks
Follow Us
Kuros Biosciences Ltd. (CSBTF)
OTHER OTC:CSBTF
Total Valuation
Kuros Biosciences has a market cap or net worth of $772.74M. The enterprise value is $430.56M.
Market Cap$772.74M
Enterprise Value$430.56M
Share Statistics
Kuros Biosciences has 38.11M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding38.11M
Owned by Insiders
Owned by Instutions
Financial Efficiency
Kuros Biosciences’s return on equity (ROE) is -0.06 and return on invested capital (ROIC) is -8.65%.
Return on Equity (ROE)-6.33%
Return on Assets (ROA)-4.40%
Return on Invested Capital (ROIC)-8.65%
Return on Capital Employed (ROCE)-7.85%
Revenue Per Employee$430,672.131
Profits Per Employee-$72,836.066
Employee Count122
Asset Turnover0.89
Inventory Turnover1.43
Valuation Ratios
The current PE Ratio of Kuros Biosciences is -213.72. Kuros Biosciences’s PEG ratio is 2.90.
PE Ratio-213.72
PS Ratio10.51
PB Ratio13.52
Price to Fair Value13.52
Price to FCF391.61
Price to Operating Cash Flow252.93
PEG Ratio2.90
Income Statement
In the last 12 months, Kuros Biosciences had revenue of $52.54M and earned -$8.89M in profits. Earnings per share was -$0.25.
Revenue$52.54M
Gross Profit$45.34M
Operating Income-$4.92M
Pretax Income-$7.37M
Net Income-$8.89M
EBITDA-1.43M
Earnings Per Share (EPS)-0.25
Cash Flow
In the last 12 months, operating cash flow was -$2.42M and capital expenditures -$849.00K, giving a free cash flow of -$3.26M billion.
Operating Cash Flow-$2.42M
Free Cash Flow-$3.26M
Free Cash Flow per Share-$0.09
Dividends & Yields
Kuros Biosciences pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield0.26%
Earnings Yield-0.47%
Stock Price Statistics
Beta0.11
52-Week Price Change181.05%
50-Day Moving Average22.61
200-Day Moving Average22.05
Relative Strength Index (RSI)58.39
Average Volume (3m)456.00
Important Dates
Kuros Biosciences upcoming earnings date is Aug 13, 2025, TBA.
Last Earnings DateMar 11, 2025
Next Earnings DateAug 13, 2025
Ex-Dividend Date―
Financial Position
Kuros Biosciences as a current ratio of 2.14, with Debt / Equity ratio of 0.03
Current Ratio2.14
Quick Ratio1.69
Debt to Market Cap0.00
Net Debt to EBITDA27.93
Interest Coverage Ratio-33.52
Taxes
In the past 12 months, Kuros Biosciences has paid $1.51M in taxes.
Income Tax$1.51M
Effective Tax Rate-11.06%
Enterprise Valuation
Kuros Biosciences EV to EBITDA ratio is -1.39K, with an EV/FCF ratio of 383.89.
EV to Sales10.30
EV to EBITDA-1.39K
EV to Free Cash Flow383.89
EV to Operating Cash Flow247.94
Balance Sheet
Kuros Biosciences has $14.28M in cash and marketable securities with $5.57M in debt, giving a net cash position of -$8.71M billion.
Cash & Marketable Securities$14.28M
Total Debt$5.57M
Net Cash-$8.71M
Net Cash Per Share-$0.23
Tangible Book Value Per Share$0.65
Margins
Gross margin is 82.10%, with operating margin of -6.61%, and net profit margin of -4.92%.
Gross Margin82.10%
Operating Margin-6.61%
Pretax Margin-4.43%
Net Profit Margin-4.92%
EBITDA Margin-0.74%
EBIT Margin-4.23%
Analyst Forecast
The average price target for Kuros Biosciences is , which is 11.43% higher than the current price. The consensus rating is
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast
EPS Growth Forecast